The Journal of Experimental Medicine
BioLegend: New Th17, Treg Tools
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 18 March 2002. doi:10.1084/jem.20011299
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sárdy, M.
Right arrow Articles by Smyth, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sárdy, M.
Right arrow Articles by Smyth, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© Rockefeller University Press, 0022-1007/2002/3/747/ $5.00
The Journal of Experimental Medicine, Volume 195, Number 6, March 18, 2002 747-757


Original Article

Epidermal Transglutaminase (TGase 3) Is the Autoantigen of Dermatitis Herpetiformis

Miklós Sárdy1, Sarolta Kárpáti1, Barbara Merkl2, Mats Paulsson2 and Neil Smyth2

1 Department of Dermato-Venereology, Semmelweis University, H-1085 Budapest, Hungary
2 Institute for Biochemistry II, Medical Faculty, University of Cologne, D-50931 Cologne, Germany

Address correspondence to Dr. M. Sárdy, Dept. of Dermato-Venereology, Semmelweis University, H-1085 Budapest, Mária u. 41, Hungary. Phone: 36-1-266-0465/5718; Fax: 36-1-267-6974; E-mail: sardy{at}bor.sote.hu

Gluten sensitivity typically presents as celiac disease, a common chronic small intestinal disorder. However, in certain individuals it is associated with dermatitis herpetiformis, a blistering skin disease characterized by granular IgA deposits in the papillary dermis. While tissue transglutaminase has been implicated as the major autoantigen of gluten sensitive disease, there has been no explanation as to why this condition appears in two distinct forms. Here we show that while sera from patients with either form of gluten sensitive disease react both with tissue transglutaminase and the related enzyme epidermal (type 3) transglutaminase, antibodies in patients having dermatitis herpetiformis show a markedly higher avidity for epidermal transglutaminase. Further, these patients have an antibody population specific for this enzyme. We also show that the IgA precipitates in the papillary dermis of patients with dermatitis herpetiformis, the defining signs of the disease, contain epidermal transglutaminase, but not tissue transglutaminase or keratinocyte transglutaminase. These findings demonstrate that epidermal transglutaminase, rather than tissue transglutaminase, is the dominant autoantigen in dermatitis herpetiformis and explain why skin symptoms appear in a proportion of patients having gluten sensitive disease.

Key Words: gluten sensitive enteropathy • celiac disease • IgA • immune complex • skin


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS